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SINCE THE EARLY WORK of Evans
(1972), the presence of macrophages,
sometimes in large numbers, in tumours
has become increasingly well documented,
but the significance of this phenomenon is
still open to question (e.g. James et al.,
1.977; Eccles, 1978; Woodruff, 1980). As a
further step towards finding the explana-
tion, we have investigated the effect of
systemic injection of Corynebacterium par-
vuan (CP) on the number and activity of
macrophages in primary and transplanted
murine fibrosarcomas by measuring in
tumour-cell suspensions the proportion of
Fc-receptor-bearing (FcR+) and phago-
cytic cells, and also their Fe-receptor
avidity (EA50). The EA50 of macrophages
in the peritoneal cavity and blood in-
creases after i.p. injection ofinflammatory
stimuli such as CP (Moore & McBride,
1980; McBride & Moore, 1982). The extent
of the increase has, as far as has been
studied, correlated with the strength ofthe
inflammatory stimulus as measured by
other indices of macrophage stimulation/
activation. The EA50 can therefore be used
to measure functional changes in macro-
phage populations that may occur inde-
pendently of changes in cell number.
Tumourswere induced in adult (17-22 g)
female CBA and BALB/c mice (Bantin
and Kingman Ltd, Hull), either by a single
s.c. injection of 01 or 0 5 mg 20-methyl-
cholanthrene (MC) dissolved in 0'1. ml
tricaprillin to the thigh or by s.c. implant-
ation of a Millipore disc (6 mm diam, pore
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diam 0-22 ,um) impregnated with 041 mg
MC to the abdominal wall. Some mice
received an i.v. injection of 0 7 mg CP
(Coparvax, Wellcome Foundation, Beck-
enham) every 4 weeks, starting 4 days
before administration of the carcinogen;
the others were untreated. The tumours
were harvested when the thickness of the
tumour-bearing limb had increased by
5-8 mm or for disc tumours when the
product ofthe height and the diameters in
2 dimensions was 125. Further details are
reported in 2 other studies in which these
tumours were used (Wroodruff et al.,
1982a, b). Cell suspensions were prepared
by disaggregating the tumour in the
presence of 0.0500 Dispase and 0.002%
deoxyribonuclease (Moore & McBride,
1980). Three tumours induced in untreated
mice with 0 1 mg MC were passaged x 6 by
s.c. injection of 105 viable cells to the thigh
of 5 untreated mice and of 5 mice which
received a single i.v. injection of 0 7 mg
CP 2-4 days after tumour inoculation.
Suspensions were made from tumours after
each passage, when the mean increase in
limb thickness was 3 mm, the largest
and smallest tumours being discarded. The
others were individually assessed for their
macrophage content and EA50 and a pool
of the 3 was used for the next passage.
The percentage of FcR+ cells in the
tumours was determined in triplicate by
mixing 0-1 ml tumour-cell suspension
(5 X 106 cells/ml) with 041 ml of a suspen-
sion of bovine erythrocytes sensitized withC. PARVUM AND INTRATUMORAL MACROPHAGES
a maximal subagglutinating quantity of
rabbit IgG antibody (EA), centrifuging at
200 g for 5 min, incubating at room
temperature for 30 min, resuspending in a
drop of 1% crystal violet, and counting
the proportion of rosette-forming cells.
The percentage of phagocytic cells was
determined with latex particles and also
with EA as described previously (Moore &
McBride, 1980). Both tests were performed
in duplicate and agreed closely; the results
were therefore pooled and averaged. The
EA50 was measured on rapidly adherent
macrophages (Moore & McBride, 1980). In
brief, prewarmed (37°C) tumour-cell sus-
pensions containing 106 cells in 0 5 ml
Hanks' BSS with 20% FCS were put into
16mm wells of Costar culture plates
(Arnold R. Horwell, London). After 5 min
at 37°C the plates were shaken, incubated
for a further 5 min, and the rapidly
adhering cells, which were virtually all
macrophages, were washed x 3 with BBS.
Aliquots of bovine erythrocytes sensitized
with a maximal subagglutinating quantity
of EA and with doubling dilutions thereof
were gently centrifuged on to the macro-
phage monolayers and incubated for
30 min at room temperature. The non-
adherent EA were washed off and the
percentage of adherent cells forming
rosettes with each EA suspension were
counted. Very occasionally, not all adher-
ent cells formed rosettes with the maxi-
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FIG. 1. The correlation between Fc-receptor-
bearing and phagocytic cells within primary
MC-induced tumours (r= 0826).
70
mally sensitized EA. If this value was less
than 7500 the test was abandoned; other-
wise the assumption was made that cells
that did not rosette were not macrophages.
The EA50 was calculated by graphing the
percentage of cells binding EA against the
log reciprocal IgG concentration and
taking the value ofthe dilution that would
give EA capable of binding to 5000 of the
adherent cells.
The percentage of intratumour phago-
cytes was, on average, 60% less than the
percentage of FcR+ cells, but they were
closely correlated (Fig. 1). This was
expected since both measure mainly mac-
rophages. In the primary tumours (Table)
the proportion of macrophages and the
EA50 differed considerably in different
TABLE. Primary tumours
Mouse Do
strain
CBA
CBA
CBA
CBA
>se of MC
(mg) C. I
0-1
0-1
0-5
0-5
CBA 0.1
(on Disc)
BALB/c 0-1
Phagocytes* EA*
parvum (0) (%)
- 27 27
(± 3) (±4)
+ 27 32
(±3) (±6)
- 22 36
(±7) (±6)
+ ND 36
(±+4)
- 29 36
(±5) (±4)
- 31 43
(±3) (±6)
* Mean + s.e.; 6-9 mice per group.
t Mean. In brackets, log mean + s.e.
I Time to reach 5 mm increase in leg diameter.
EA5ot
168
(2-22+ 1-40)
204
(2 - 31 + 0 - 09)
275
(2-44+ 0 -16)
229
(2-36+ 0-12)
199
(2 30+ 0-20)
375
(2-57+0-03)
Latent periodl
(days)
192
(± 20)
152
(± 9)
124
(± 12)
149
(±7)
127
(±5)
130
(±9)
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FIG. 2.-Alterations on passage (Pass)
tumours (W58, W63, W66) grown ir
treated (solid lines) or CP-treated (d
lines) mice in the number and level of a
ation ofintratumoral macrophages, an
time for the tumour to grow to a star
size (days to + 3 mm). Error bar,
omitted for clarity.
tumours, but there was no evider
either was influenced by CP adn
tion during carcinogenesis. There
correlation between the EA50 for
phages and their number within'
It is noteworthy that, as pr(
reported, CP administration dur
cinogenesis failed to influence thi
peutic response of the tumour tc
subsequent transplantation, and it
affect the sensitivity ofthe tumoui
the cytotoxic effect of CP-activat
toneal exudate macrophages i?
though it did increase the immuno
of tumours which developed in resj
a small dose (0.1 mg) of MC (Woc
al., 1982a). The influence of CP on
latency depended upon the dose c
W66 nogen used, and this point also has been
discussed in Woodruff et at. (1982b).
The results of tumour passage on the
--- macrophages within 3 ofthese tumours are
shown in Fig. 2. The percentage of
phagocytic and FcR- cells dropped
sharply after 1-5 passages, and did not
recover, whether the hosts received CP or
not. We believe that this is a meaningful
-' change; the test is highly reproducible
from day to day. The decrease in the
number of macrophages was associated
with faster growth of the transplants. In
contrast, the EA50 increased markedly
after 1 or more passages in the CP-treated
mice, whereas in the untreated mice it
[_b __ either remained constant or at least
showed no consistent change. The differ-
ences between the 2 groups were in almost
all cases highly significant and were
reproduced in everypassage.
In this study we have shown a consist-
JIrL. ent increase in the EA50 ofmacrophages in
0 13 6 passaged tumours of hosts treated sys-
PASS temically with CP. This agrees with the
of 3 observations of McBride & Moore (1982)
a un- who found with another tumour system 3CttV- that administration of CP led to the Id the emergence in tumour transplants of a
adard subpopulation of small, highly active
macrophages. It seems quite possible that
these changes in macrophage activity are
responsible for the significant slowing of
ice that tumour growth noted for all 3 tumours
niinistra- after CP administration (Fig. 2). The
was no finding that the number of macrophages
macro- within the tumours is not influenced by
tumour. CP is in agreement with other workers
eviously (Thomson et al., 1979; Gebhardt & Fisher,
ing car- 1979).
e thera- The failure to detect any increase in
CP on EA5o of macrophages from primary tum-
did not ours attributable to CP may be due to the
r cells to marked variation between tumours. Alter-
Jed peri- natively, or in addition, it seems likely
a vitro, thatrepeated transplantation gives oppor-
genicity tunities for selection of tumour cells
ponse to particularly well adapted forgrowth under
)druff et set conditions oftransplantation, the host
tumour response playing a relevant part in the
)f carci- establishment of this balance in favour of
r-i 1-1
--l
n r F
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the tumour. This may explain the drop in
macrophage number in the early phases of
transplantation, findings that are sup-
ported by Pross & Kerbel (1976). By
affecting the host response to passaged
tumours, CP is more likely to have a
therapetuic effect than in primary tum-
ours, where this selection process has not
operated. The rules determining host
elements and their functions within prim-
ary tumours may be different from those
for transplanted tumours. In more general
terms, the data presented here should not
be interpeted in isolation, but require to be
taken into account in attempting to
develop a unifying hypothesis to account
for the presence of macrophages in tum-
ours and for the capacity of macro-
phages under different conditions to
stimulate orinhibit tumourgrowth.
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